|
[1]BASS G,GILANI SN,WALSH TN.Validating the 5Fs mnemonic for cholelithiasis:time to include family history[J].Postgrad Med J,2013,89(1057):638-641.
|
|
[2]FRADIN K,RACINE AD,BELAMARICH PF.Obesity and symptomatic cholelithiasis in childhood:epidemiologic and case-control evidence for a strong relation[J].J Pediatr Gastroenterol Nutr,2014,58(1):102-106.
|
|
[3]GU YC,HE XD,YU JC,et al.Metabolism-related risk factors of cholelithiasis among Beijing residents:a case-control study[J].Acta Acad Med Sin,2012,34(1):38-40.(in Chinese)古应超,何小东,于健春,等.北京地区代谢因素与胆囊结石患病风险的病例对照研究[J].中国医学科学院学报,2012,34(1):38-40.
|
|
[4]ATAMER A,OVUNC AO,YESIL A,et al.Evaluation of leptin and insulin resistance in patients with cholelithiasis[J].Indian J Biochem Biophys,2013,50(4):266-272.
|
|
[5]SARAC S,ATAMER A,ATAMER Y,et al.Leptin levels and lipoprotein profiles in patients with cholelithiasis[J].J Int Med Res,2015,pii:0300060514561134.
|
|
[6]HYOGO H,ROY S,PAIGEN B,et al.Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts[J].J Biol Chem,2002,277(37):34117-34124.
|
|
[7]CHAIT A,BIERMAN EL,ALBERS JJ.Low-density lipoprotein receptor activity in cultured human skin fibroblasts.Mechanism of insulin-induced stimulation[J].J Clin Invest,1979,64(5):1309-1319.
|
|
[8]LORIA P,LONARDO A,LOMBARDINI S,et al.Gallstone disease in non-alcoholic fatty liver:prevalence and associated factors[J].J Gastroenterol Hepatol,2005,20(8):1176-1184.
|
|
[9]FRACANZANI AL,VALENTI L,RUSSELLO M,et al.Gallstone disease is associated with more severe liver damage in patients with non-alcoholic fatty liver disease[J].PLoS One,2012,7(7):e41183.
|
|
[10]RAMOS-de la MA,REMES-TROCHE JM,ROESCH-DIETLEN FB,et al.Routine liver biopsy to screen for nonalcoholic fatty liver disease(NAFLD)during cholecystectomy for gallstone disease:is it justified?[J].J Gastrointest Surg,2008,12(12):2097-2102.
|
|
[11]KOLLER T,KOLLEROVA J,HLAVATY T,et al.Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors[J].Scand J Gastroenterol,2012,47(2):197-203.
|
|
[12]CHEN YF,WU ZJ.Pathogenesis and risk factors of cholesterol gallstones in patients with non-alcoholic fatty liver disease[J].J Clin Hepatol,2013,29(12):952-955.(in Chinese)陈永芳,吴战军.非酒精性脂肪性肝病患者并发胆固醇胆结石的发病机制及危险因素[J].临床肝胆病杂志,2013,29(12):952-955.
|
|
[13]LI CP,HWANG SJ,LEE FY,et al.Evaluation of gallbladder motility in patients with liver cirrhosis relationship to gallstone formation[J].Dig Dis Sci,2000,45(6):1109-1114.
|
|
[14]COELHO JC,SLONGO J,DAMBROSKI SILVA A,et al.Prevalence of cholelithiasis in patients subjected to liver transplantation for cirrhosis[J].J Gastrointestin Liver Dis,2010,19(4):405-408.
|
|
[15]BUTT Z,HYDER Q.Cholelithiasis in hepatic cirrhosis:evaluating the role of risk factors[J].J Pak Med Assoc,2010,60(8):641-644.
|
|
[16]LIU XW,LU XH.Incidence of gallstones with cirrhosis patients[J].Chin J Clin Gastroenterol,1993,5(1):14-15.(in Chinese)刘喜文,陆星华.肝硬化患者胆结石的发生率[J].临床消化病杂志,1993,5(1):14-15.
|
|
[17]POMERANZ IS,SHAFFER EA.Abnormal gallbladder emptying in a subgroup of patients with gallstone[J].Gastroenterology,1985,88(3):787.
|
|
[18]LUO M,SUN YW,WU ZY,et al.The motility of the gallbladder in patients with liver cirrhosis[J].J Surg Pract,2002,7(4):283-286.(in Chinese)罗蒙,孙勇伟,吴志勇,等.肝硬化伴胆囊结石病人的胆囊动力学研究[J].外科理论与实践,2002,7(4):283-286.
|
|
[19]FORNARI F,CIVATDI G,BUSCATINI E,et al.Cirrhosis of the liver-a risk factor for development of cholelithiasis males[J].Dig Dis Sci,1990,35(11):1403-1408.
|
|
[20]ZHU JF,SHAN KC,DONG L,et al.Changes in gallbladder contraction function in patients with cirrhotic portal hypertension[J].Chin J Surg,1993,31(1):34-36.(in Chinese)朱江帆,单孔成,董磊,等.肝硬变门静脉高压症胆囊收缩功能的改变[J].中华外科杂志,1993,31(1):34-36.
|
|
[21]MILOVANOVIC B,MILINIC N,TRIFUNOVIC D,et al.Autonomic dysfunction in alcoholic cirrhosis and its relation to sudden cardiac death risk predictors[J].Gen Physiol Biophys,2009,28(1):251-261.
|
|
[22]CHAWLA A,PUTHUMANA L,THULUVATH PJ.Autonomic dysfunction and cholelithiasis in patients with cirrhosis[J].Dig Dis Sci,2001,46(3):495-498.
|
|
[23]VAKHRUSHEV IaM,GORBUNOV AIU,TRONINA DV,et al.Cholelithiasis as a possible manifestation of systemic digestive diseases[J].Ter Arkh,2015,87(2):54-58.
|
|
[24]XIAN GZ,WU SD,CHEN CC,et al.Western blotting in the diagnosis of duodenal-biliary and pancreaticobiliary refluxes in biliary diseases[J].Hepatobiliary Pancreat Dis Int,2009,8(6):608-613.
|
|
[25]WU SD,YU H,WANG HL,et al.The relationship between Oddi's sphincter and bile duct pigment gallstone[J].Chin J Surg,2007,45(1):58-61.(in Chinese)吴硕东,于宏,王昊霖,等.Oddi括约肌与胆管色素结石形成关系的探讨[J].中华外科杂志,2007,45(1):58-61.
|
|
[26]TOMTITCHONG P,TIEMTANOM S,EIAMTRAKUL S,et al.Gastroduodenal pathology in patients with asymptomatic gallbladder stones[J].Hepatogastroenterology,2014,61(129):236-239.
|
|
[27]WU WC,ZHAO W,LI S.Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats[J].World J Gastroenterol,2008,14(2):313-317.
|
|
[28]KAUR J,RANA SV,GUPTA R,et al.Prolonged orocecal transit time enhances serum bile acids through bacterial overgrowth,contributing factor to gallstone disease[J].J Clin Gastroenterol,2014,48(4):365-369.
|
|
[29]WANG DQ,COHEN DE,CAREY MC.Biliary lipids and cholesterol gallstone disease[J].J Lipid Res,2009,50(Suppl):s406-s411.
|
|
[30]FAN Y,WU SD,SUN L,et al.Possible relationship between intestinal barrier function and formation of pigment gallstones in hamsters[J].Hepatobiliary Pancreat Dis Int,2008,7(5):529-532.
|
|
[31]SUN SL,WU SD,SUI DM,et al.Determination of intestinal permeability in cholelithiasis patients by oral administration of technetium-99m-diethylenetriaminepentaacetatic acid[J].Natl Med J China,2007,87(7):464-467.(in Chinese)孙韶龙,吴硕东,隋东明,等.口服99Tmc-DTPA检测胆石症患者肠黏膜通透性[J].中华医学杂志,2007,87(7):464-467.
|
|
[32]BAI SY,XIAO SJ,WEI N.Clinical study of changes in intestinal permeability in patients with gallstones of different distribution and properties[J].J Clin Hepatol,2014,30(6):546-548.(in Chinese)白顺滟,肖思洁,魏娜.不同部位及性质胆石症患者肠黏膜通透性改变的临床分析[J].临床肝胆病杂志,2014,30(6):546-548.
|
|
[33]SAYIN SI,WAHLSTROM A,FELIN J,et al.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid,a naturally occurring FXR antagonist[J].Cell Metab,2013,17(2):225-235.
|
|
[34]WU T,ZHANG Z,LIU B,et al.Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study[J].BMC Genomics,2013,14:669.
|
|
[35]WEGRZYN P,POPIOLEK M,PRZYBYLOWSKI P,et al.The risk of cholelithiasis in patients after heart transplantation[J].Arch Med Sci,2014,10(1):53-57.
|
|
[36]SHIINA Y,TOYODA T,KAWASOE Y,et al.The prevalence and risk factors for cholelithiasis and asymptomatic gallstones in adults with congenital heart disease[J].Int J Cardiol,2011,152(2):171-176.
|
|
[37]BHADADA SK,BHANSALI A,SHAH VN,et al.High prevalence of cholelithiasis in primary hyperparathyroidism:a retrospective analysis of 120 cases[J].Indian J Gastroenterol,2011,30(2):100-101.
|
|
[38]QIN J,LI Y,CAI Z,et al.A metagenome-wide association study of gut microbiota in type 2 diabetes[J].Nature,2012,490(7418):55-60.
|
|
[39]LI F,JIANG C,KRAUSZ KW,et al.Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity[J].Nat Communi,2013,4(3):2384.
|
|
[40]QIN N,YANG F,LI A,et al.Alterations of the human gut microbiome in liver cirrhosis[J].Nature,2014,513(7516):59-64.
|
DownLoad: